An Introduction to Diabetic Retinopathy
Advances in pharmacotherapy following the introduction of anti-VEGF agents and intravitreal steroids have transformed the diabetic retinopathy treatment landscape; and new imaging techniques, such as optical coherence tomography-angiography (OCT-A), have helped to guide treatment.
Browse the content below, to see leading experts discuss the latest data in video interviews and short articles from our conference hub. You can also view the selection of peer-reviewed articles from our journals. If you’re looking to learn more about the impact of these developments on patient outcomes, our educational activities are a great resource.
Our supporting partners do not constitute an endorsement of the content on this page.
Diabetic Retinopathy Content
Francesco Bandello, ESCRS 2020 – Anti-vascular Endothelial Growth Factor Agents and Laser for Treatment of Proliferative Diabetic Retinopathy
It was a pleasure to catch up with our Editorial Board member, Prof. Francesco Bandello (University Vita-Salute, Scientific Institute San Raffaele, Milano, Italy), who talked us through his recent research on anti-vascular endothelial growth factor agents combined with laser for the treatment of proliferative diabetic retinopathy. Questions Could you tell us a little about your […]
Michael Abramoff, EURETINA 2019 – AI-based diabetic retinopathy screening
AI was a hot topic at ESRCS 2019, so we were honoured to meet with Michael Abramoff (University of Iowa) to discuss his latest research around an autonomous AI diagnostic system to assist with the diagnosis of diabetic retinopathy. Questions: 1. What are the limitations of current diagnosis of diabetic retinopathy? (0:04) 2. Could you […]
José Cunha Vaz, EURETINA 2019 – Advances in diabetic retinopathy
Jose Cunha-Vaz (AIBILI, Coimbra, Portugal) discusses the most important updates on diabetic retinopathy from EURETINA 2019, and shares advice with early career ophthalmologists on having a successful career. Questions: 1. What recent advances in diabetic retinopathy have had the biggest impact on your practice? 0:04 2. What are the most important updates in the area […]
Thomas Fenech, SOE 2019 – Updates in diabetic retinopathy
Thomas Fenech (Mater Dei Hospital, Msida, Malta) shares his thoughts on the most recent developments in diabetic retinopathy and the most promising areas of research for the future. Questions: 1. What have been the most significant recent developments in diabetic retinopathy? (0:04) 2. Discuss the current unmet needs and/or the challenges you face when treating […]
Matias Iglicki, SOE 2019 – ICO-Allergan Advanced Research Fellowship Award 2019
We caught up with Matias Iglicki, of the University of Buenos Aires, Argentina, at the SOE 2019 annual meeting. Dr Iglicki was recently awarded the ICO-Allergan Advanced Research Fellowship Award for his work in ‘Early Diagnosis of Diabetic Retinopathy Lesions using Telemedicine’, which he discusses in this video. 1. You were recently granted the ICO-Allergan […]
Optical Coherence Tomography Angiography
US Ophthalmic Review. 2018;11(2):91–7 DOI: https://doi.org/10.17925/USOR.2018.11.2.91
Optical coherence tomography (OCT) is a revolutionary tool that plays a key role in the management of various retinal pathologies. The salient features of OCT are its non-invasive nature and its ability to image intraocular structures in vivo with resolution comparable to that of histological sections.1 Of late, various angiography tools based on OCT technology […]
José Cunha-Vaz, WOC 2018 – Challenges and Recent Developments in DME
At WOC 2018, José Cunha-Vaz (University of Coimbra, Coimbra, Portugal) discussed his experience with treating patients with DME. The most significant developments in the area of DME are OCT imaging and the availability of anti-VEGF agents, which completely revolutionised treatment. The major issue is individualising treatment to each patient, as response varies greatly between different […]
Diabetic Retinopathy Screening Methods and Programmes Adopted in Different Parts of the World – Further Insights
European Ophthalmic Review, 2015;9(2):161–2 DOI: http://doi.org/10.17925/EOR.2015.09.02.161
We recently published a review of diabetic retinopathy (DR) screening methods and programmes adopted in different parts of the world.1 After publication we learnt about more DR screening programmes and believed that this important information should be supplemented with data from Portugal, Denmark and the US (see Table 1). PortugalRibeiro et al.2 presented a study […]
Wide-field Imaging of Retinal Diseases
US Ophthalmic Review, 2015;8(2):125–31 DOI: http://doi.org/10.17925/USOR.2015.08.02.125
Retinal imaging serves as a critical adjunct to the diagnosis, monitoring, and treatment of numerous ocular diseases. Since the invention of the direct ophthalmoscope by Hermann von Helmholtz in 1851, techniques to visualize the fundus have grown exponentially both in number and sophistication. Notably, wide-field retinal imaging has taken center stage over the past 2 […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!